Item 2.02 Results of Operations and Financial Condition.

On May 6, 2021, Puma Biotechnology, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2021. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

The information in this Item 2.02, including the accompanying exhibit, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



99.1      Press Release dated May 6, 2021

104     Cover Page Interactive Data File (formatted as inline XBRL and contained
        in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses